<?xml version='1.0' encoding='utf-8'?>
<document id="16632523"><sentence text="Retinoids activate the RXR/SXR-mediated pathway and induce the endogenous CYP3A4 activity in Huh7 human hepatoma cells." /><sentence text="Steroid and xenobiotic receptor (SXR) or human pregnane X receptor (hPXR) dimerizes with retinoid X receptor (RXR) and regulates the transcription of genes encoding xenobiotic-metabolizing enzymes such as CYP3A4"><entity charOffset="0-7" id="DDI-PubMed.16632523.s2.e0" text="Steroid" /></sentence><sentence text=" Rifampin, the classical activator of CYP3A4, binds to SXR directly"><entity charOffset="1-9" id="DDI-PubMed.16632523.s3.e0" text="Rifampin" /></sentence><sentence text=" It is unclear whether various natural and synthetic retinoids can regulate the expression of CYP3A4"><entity charOffset="53-62" id="DDI-PubMed.16632523.s4.e0" text="retinoids" /></sentence><sentence text=" To evaluate the effects of retinoids on the RXR/SXR-mediated pathway, transient transfection assays were performed on both CV-1 and human hepatoma Huh7 cells using a reporter construct containing multiple RXR/SXR consensus binding elements (an everted repeat with a 6-nucleotide spacer, ER-6)"><entity charOffset="28-37" id="DDI-PubMed.16632523.s5.e0" text="retinoids" /></sentence><sentence text=" The results revealed that eight out of 13 retinoids screened significantly induced the RXR/SXR-mediated pathway in Huh7 cells" /><sentence text=" At an equal molar concentration, the acid forms (9-cis-RA, 13-cis-RA, and all-trans-RA) or aldehyde, the direct precursor of acid (9-cis-retinal and 13-cis-retinal), exhibited a greater or similar potency than rifampin"><entity charOffset="75-87" id="DDI-PubMed.16632523.s7.e0" text="all-trans-RA" /><entity charOffset="92-100" id="DDI-PubMed.16632523.s7.e1" text="aldehyde" /><entity charOffset="211-219" id="DDI-PubMed.16632523.s7.e2" text="rifampin" /><pair ddi="false" e1="DDI-PubMed.16632523.s7.e0" e2="DDI-PubMed.16632523.s7.e0" /><pair ddi="false" e1="DDI-PubMed.16632523.s7.e0" e2="DDI-PubMed.16632523.s7.e1" /><pair ddi="false" e1="DDI-PubMed.16632523.s7.e0" e2="DDI-PubMed.16632523.s7.e2" /><pair ddi="false" e1="DDI-PubMed.16632523.s7.e1" e2="DDI-PubMed.16632523.s7.e1" /><pair ddi="false" e1="DDI-PubMed.16632523.s7.e1" e2="DDI-PubMed.16632523.s7.e2" /></sentence><sentence text=" Depending on the ligands, RXR may serve as a silent or an active partner of SXR" /><sentence text=" Additionally, retinoids can increase CYP3A4 enzyme activity in Huh7 cells"><entity charOffset="15-24" id="DDI-PubMed.16632523.s9.e0" text="retinoids" /></sentence><sentence text=" To further evaluate the potential drug-drug interactions, which may be caused by retinoids, Huh7 cells were pretreated with 9-cis-RA and followed by acetaminophen"><entity charOffset="82-91" id="DDI-PubMed.16632523.s10.e0" text="retinoids" /><entity charOffset="150-163" id="DDI-PubMed.16632523.s10.e1" text="acetaminophen" /><pair ddi="false" e1="DDI-PubMed.16632523.s10.e0" e2="DDI-PubMed.16632523.s10.e0" /><pair ddi="false" e1="DDI-PubMed.16632523.s10.e0" e2="DDI-PubMed.16632523.s10.e1" /></sentence><sentence text=" We showed that 9-cis-RA enhanced the covalent binding of N-acetyl-p-quinoneimine, a toxic intermediate of acetaminophen produced by phase I enzymes oxidation"><entity charOffset="58-81" id="DDI-PubMed.16632523.s11.e0" text="N-acetyl-p-quinoneimine" /><entity charOffset="107-120" id="DDI-PubMed.16632523.s11.e1" text="acetaminophen" /><pair ddi="false" e1="DDI-PubMed.16632523.s11.e0" e2="DDI-PubMed.16632523.s11.e0" /><pair ddi="false" e1="DDI-PubMed.16632523.s11.e0" e2="DDI-PubMed.16632523.s11.e1" /></sentence><sentence text=" This result suggested that drug-drug interaction might occur between 9-cis-RA and acetaminophen in human liver cells"><entity charOffset="83-96" id="DDI-PubMed.16632523.s12.e0" text="acetaminophen" /></sentence><sentence text=" Taken together, retinoids activate the RXR/SXR-mediated pathway and regulate the expression of CYP3A4"><entity charOffset="17-26" id="DDI-PubMed.16632523.s13.e0" text="retinoids" /></sentence><sentence text=" Thus, retinoids potentially can cause drug-drug interactions when they are administered with other CYP3A4 substrates"><entity charOffset="7-16" id="DDI-PubMed.16632523.s14.e0" text="retinoids" /></sentence><sentence text="" /></document>